Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.33 USD
+0.15 (1.23%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $12.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth A Momentum A VGM
Zacks News
IQVIA (IQV) Rides on Global IT Infrastructure, Debt Remains High
by Zacks Equity Research
IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.
Here's Why You Should Retain Equifax (EFX) in Your Portfolio
by Zacks Equity Research
Equifax's (EFX) ongoing cloud data and technology transformation is aimed at driving innovation and product development.
Maximus (MMS) Up on Strategic Acquisitions Amid High Debt
by Zacks Equity Research
Maximus' (MMS) expertise in business process management, and its ability to deliver cost-effective, efficient and high-scale solutions, position it as a lucrative partner to governments.
Insperity (NSP) Rides on PEO Industry Strength Amid Cost Woes
by Zacks Equity Research
Insperity (NSP) looks strong on the back of a growing PEO industry that is currently being driven by the growth of small- and medium-sized businesses.
Cross Country Healthcare (CCRN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 3.70% and 4.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include ArcBest, Atlas Air Worldwide Holdings, Cross Country Healthcare, Asbury Automotive Group and Avnet
by Zacks Equity Research
ArcBest, Atlas Air Worldwide Holdings, Cross Country Healthcare, Asbury Automotive Group and Avnet are included in this blog.
Verisk (VRSK) Announces Changes in Its Board of Directors
by Zacks Equity Research
Verisk (VRSK) announces the retirement of Scott G. Stephenson and consequent adjustments to its board of directors and executive positions.
Will Cross Country Healthcare (CCRN) Beat on Earnings in Q4?
by Zacks Equity Research
Cross Country Healthcare's (CCRN) fourth-quarter 2021 earnings and revenues are expected to have increased year over year.
Cross Country Healthcare (CCRN) Crossed Above the 20-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Cross Country Healthcare (CCRN) Crossed Above the 200-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
Earnings Estimates Moving Higher for Cross Country (CCRN): Time to Buy?
by Zacks Equity Research
Cross Country (CCRN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
H&R Block (HRB) Banks on Five-Year Strategy Amid High Debt
by Zacks Equity Research
Solid shareholder-friendly measures boost H&R Block (HRB). However, high debt is worrisome.
Trane Technologies' (TT) Growth Initiatives Impress, Debt Ails
by Zacks Equity Research
Trane Technologies (TT) continues to focus on steps to increase revenue stream from parts, services, controls, used equipment and rentals.
Can Cross Country (CCRN) Climb 25% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Cross Country (CCRN) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
5 Stocks to Add to Your Portfolio Post Broker Upgrade
by Maharathi Basu
Broker-friendly stocks like ArcBest (ARCB), Atlas Air (AAWW), Cross Country Healthcare (CCRN), Asbury Automotive (ABG) and Avnet (AVT) should grace one's portfolio.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $21.83 in the latest trading session, marking a +0.46% move from the prior day.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $22.41 in the latest trading session, marking a +0.04% move from the prior day.
Broadridge (BR) Rides on Recurring Revenues, Debt Woes Persist
by Zacks Equity Research
Broadridge (BR) has a robust business model that ensures significant recurring-fee revenues. A debt-laden balance sheet is concerning.
Zacks.com featured highlights include: Atlas Air Worldwide Holdings, ArcBest Corp., Archer Daniels, Cross Country Healthcare and Asbury Automotive Group
by Zacks Equity Research
Atlas Air Worldwide Holdings, ArcBest Corp., Archer Daniels, Cross Country Healthcare and Asbury Automotive Group are highlighted in this Screen of the Week article.
5 Stocks to Buy Following Recent Upgrade by Brokers
by Maharathi Basu
Investors should add broker-friendly stocks like ArcBest (ARCB), Archer Daniels (ADM), Atlas Air (AAWW), Cross Country Healthcare (CCRN) and Asbury Automotive (ABG) to their respective portfolios for handsome returns.
Cross Country Healthcare (CCRN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Cross Country Healthcare (CCRN) closed at $22.16 in the latest trading session, marking a +0.82% move from the prior day.
Why the Earnings Surprise Streak Could Continue for Cross Country (CCRN)
by Zacks Equity Research
Cross Country (CCRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
FTI Consulting (FCN) Appoints Senior MD for M&A and Activism
by Zacks Equity Research
FTI Consulting (FCN) welcomes Patrick Tucker to the position of senior managing director in its Mergers & Acquisitions and Activism practice within the Strategic Communications segment in New York.
Cross Country Healthcare (CCRN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Cross Country Healthcare (CCRN) closed at $17.92, marking a -0.22% move from the previous day.
ICF International (ICFI) Appoints New Chief Financial Officer
by Zacks Equity Research
ICF International (ICFI) welcomes Barry Broadus to the position of chief financial officer.